
  
    
      
        Background_NNP
        Chemokines_NNP are_VBP small_JJ ,_, positively_RB charged_VBN ,_, secreted_JJ
        proteins_NNS that_WDT consist_VBP of_IN an_DT N-_NNP terminal_NN region_NN of_IN variable_JJ
        conformation_NN ,_, three_CD antiparallel_NN beta-pleated_JJ sheets_NNS
        connected_VBN by_IN loops_NNS ,_, and_CC a_DT C-_NNP terminal_NN alpha_NN helix_NN [_NN 1_CD ]_NN ._.
        These_DT proteins_NNS are_VBP multifunctional_NN ,_, with_IN different_JJ regions_NNS
        of_IN the_DT molecules_NNS ,_, in_IN particular_JJ the_DT N-_NNP and_CC C-_NNP termini_NN ,_,
        performing_VBG specific_JJ functions_NNS [_NN e_SYM ._. g_SYM ._. [_NN 1_CD 2_CD 3_CD 4_CD ]_NN ]_NN ._.
        Chemokines_NNP are_VBP best_RBS known_VBN for_IN their_PRP$ functions_NNS in_IN
        attracting_VBG and_CC activating_VBG leukocytes_NNS ._. Shortly_RB after_IN injury_NN ,_,
        these_DT small_JJ cytokines_NNS are_VBP primarily_RB produced_VBN by_IN
        fibroblasts_NNS ,_, chemoattract_NN leukocytes_NNS and_CC activate_VBP their_PRP$
        integrins_NNS causing_VBG them_PRP to_TO adhere_VB strongly_RB to_TO the_DT
        endothelial_NN cells_NNS as_IN a_DT prelude_NN to_TO their_PRP$ migration_NN through_IN
        the_DT blood_NN vessel_NN wall_NN to_TO the_DT underlying_VBG tissue_NN and_CC towards_IN
        the_DT source_NN of_IN the_DT chemokine_NN [_NN 5_CD ]_NN ._. In_IN addition_NN to_TO these_DT
        functions_NNS during_IN the_DT early_JJ stages_NNS of_IN wound_VBD healing_VBG ,_, these_DT
        small_JJ cytokines_NNS are_VBP also_RB known_VBN to_TO be_VB involved_VBN in_IN
        re-epithelialization_JJ ,_, angiogenesis_NNS and_CC granulation_NN tissue_NN
        development_NN [_NN 3_CD 6_CD 7_CD 8_CD ]_NN ,_, processes_VBZ that_WDT are_VBP critical_JJ for_IN
        proper_JJ healing_NN ._.
        The_DT first_JJ evidence_NN that_IN chemokines_NNS are_VBP associated_VBN with_IN
        wound_VBD healing_VBG 
        in_IN vivo_NN was_VBD reported_VBN in_IN 1990_CD using_VBG
        the_DT chemokine_NN cCAF_NN (_( chicken_NN Chemotactic_NNP and_CC Angiogenic_NNP
        Factor_NN ;_: the_DT product_NN of_IN the_DT 9_CD E_NNP 3_CD gene_NN )_) ,_, a_DT CXC_NNP chemokine_NN that_WDT
        is_VBZ now_RB known_VBN to_TO be_VB the_DT ortologue_NN for_IN human_JJ IL-_NNP 8_CD [_NN 9_CD ]_NN ._.
        cCAF_NN is_VBZ expressed_VBN to_TO high_JJ levels_NNS very_RB shortly_RB after_IN
        wounding_VBG and_CC during_IN the_DT first_JJ 24_CD -_: 48_CD hours_NNS after_IN injury_NN ,_, and_CC
        remains_VBZ elevated_VBD for_IN at_IN least_JJS 16_CD days_NNS after_IN wounding_VBG [_NN 6_CD 10_CD
        ]_NN ._. It_PRP is_VBZ primarily_RB expressed_VBN by_IN the_DT fibroblasts_NNS of_IN the_DT
        granulation_NN tissue_NN ,_, especially_RB where_WRB interstitial_NN collagen_NN
        (_( Coll_NNP )_) is_VBZ abundant_JJ ,_, but_CC the_DT levels_NNS are_VBP also_RB high_JJ in_IN the_DT
        endothelial_NN cells_NNS of_IN the_DT microvessels_NNS ,_, in_IN the_DT healing_NN
        epidermis_NNS and_CC in_IN the_DT connective_JJ tissue_NN beneath_IN the_DT skin_NN [_NN 6_CD
        11_CD ]_NN ._. In_IN the_DT chicken_NN chorioallantoic_JJ membrane_NN (_( CAM_NNP )_) assay_NN ,_,
        low_JJ concentration_NN of_IN cCAF_NN results_NNS in_IN chemotaxis_NNS of_IN
        monocyte_NN /_NN macrophages_NNS and_CC lymphocytes_NNS and_CC the_DT formation_NN of_IN a_DT
        granulation-like_JJ tissue_NN beneath_IN the_DT chemokine-containing_JJ
        pellet_NN [_NN 3_CD ]_NN ._. After_IN four_CD days_NNS of_IN exposure_NN to_TO this_DT
        chemokine_NN ,_, the_DT ectoderm_NN of_IN the_DT CAMs_NNP becomes_VBZ thickened_JJ and_CC
        the_DT amount_NN of_IN fibrillar_NN collagen_NN in_IN the_DT tissue_NN is_VBZ markedly_RB
        increased_VBN ,_, strongly_RB suggesting_VBG that_DT cCAF_NN is_VBZ able_JJ to_TO
        initiate_VB some_DT of_IN the_DT primary_JJ events_NNS that_WDT lead_VBP to_TO
        granulation_NN tissue_NN formation_NN [_NN 3_CD ]_NN ._.
        Fibroblasts_NNP are_VBP important_JJ cells_NNS in_IN the_DT healing_NN process_NN ._.
        Upon_IN injury_NN ,_, they_PRP are_VBP activated_VBN by_IN the_DT cytokines_NNS and_CC growth_NN
        factors_NNS released_VBN during_IN the_DT coagulation_NN process_NN to_TO produce_VB
        chemokines_NNS and_CC additional_JJ cytokines_NNS and_CC growth_NN factors_NNS that_WDT
        are_VBP important_JJ in_IN setting_VBG up_RP the_DT cascade_NN of_IN events_NNS that_WDT lead_VBP
        to_TO granulation_NN tissue_NN formation_NN ._. Activated_NNP fibroblasts_NNS
        proliferate_VBP and_CC migrate_VB across_IN the_DT provisional_JJ matrix_NN
        formed_VBN by_IN the_DT fibrin-plasma_JJ fibronectin_NN (_( FN_NNP )_) clot_NN ._. As_IN the_DT
        clot_NN is_VBZ digested_VBN by_IN plasmin_NN ,_, fibroblasts_NNS replace_VBP it_PRP with_IN
        cellular_JJ FN_NNP ,_, tenascin_NN (_( TN_NNP )_) and_CC Coll_NNP III_NNP [_NN 12_CD 13_CD ]_NN ._. These_DT
        extracellular_NN matrix_NN proteins_NNS are_VBP critical_JJ for_IN migration_NN of_IN
        endothelial_NN cells_NNS ,_, keratinocytes_NNS and_CC additional_JJ fibroblasts_NNS
        into_IN the_DT wound_NN and_CC are_VBP important_JJ for_IN proper_JJ generation_NN of_IN
        healthy_JJ healing_NN tissue_NN ._. Some_DT of_IN the_DT fibroblasts_NNS
        differentiate_VB into_IN myofibroblasts_NNS ,_, which_WDT contract_VBP to_TO close_VB
        the_DT wound_NN [_NN 4_CD 14_CD 15_CD ]_NN ._. Myofibroblasts_NNP are_VBP fibrogenic_JJ ,_,
        showing_VBG elevated_VBD expression_NN of_IN interstitial_NN collagens_NNS ,_,
        laminin_NN ,_, FN_NNP and_CC TN_NNP ,_, and_CC inhibitors_NNS of_IN matrix_NN
        metalloproteinases_NNS such_JJ as_IN TIMP-_NNP 1_CD [_NN 15_CD 16_CD 17_CD 18_CD 19_CD ]_NN ._.
        Because_IN cCAF_NN is_VBZ expressed_VBN highly_RB in_IN the_DT granulation_NN tissue_NN
        of_IN wounds_NNS in_IN areas_NNS where_WRB ECM_NNP is_VBZ abundant_JJ [_NN 3_CD 6_CD 11_CD ]_NN ,_, and_CC
        it_PRP stimulates_NNS fibroblasts_NNS to_TO differentiate_VB into_IN
        myofibroblasts_NNS [_NN 4_CD ]_NN ,_, we_PRP investigated_VBD whether_IN this_DT
        chemokine_NN stimulates_NNS the_DT production_NN of_IN the_DT four_CD major_JJ ECM_NNP
        molecules_NNS mentioned_VBN above_IN ,_, interstitial_NN Colls_NNP I_PRP and_CC III_NNP ,_, TN_NNP
        and_CC cellular_JJ FN_NNP ._. Here_RB we_PRP show_VBP that_IN cCAF_NN stimulates_NNS cultures_NNS
        of_IN fibroblasts_NNS to_TO produce_VB TN_NNP ,_, FN_NNP ,_, and_CC Coll_NNP I_PRP ,_, albeit_IN with_IN
        different_JJ dynamics_NNS and_CC that_IN these_DT ECM_NNP molecules_NNS are_VBP also_RB
        increased_VBN in_IN wounded_VBN tissues_NNS treated_VBN with_IN cCAF_NN ._.
      
      
        Results_NNS
        
          Effects_NNPS of_IN cCAF_NN and_CC its_PRP$ peptides_NNS on_IN the_DT production_NN
          of_IN TN_NNP
          In_IN adults_NNS ,_, TN_NNP ,_, specifically_RB TN_NNP C_NNP ,_, is_VBZ present_JJ almost_RB
          exclusively_RB in_IN the_DT granulation_NN tissue_NN of_IN healing_NN wounds_NNS [_NN
          12_CD 24_CD ]_NN ._. In_IN addition_NN to_TO providing_VBG a_DT matrix_NN for_IN rapid_JJ
          migration_NN of_IN cells_NNS during_IN wound_VBD repair_NN ,_, TN_NNP supports_VBZ
          differentiation_NN of_IN fibroblasts_NNS into_IN myofibroblasts_NNS [_NN 25_CD ]_NN
          ,_, which_WDT then_RB produce_VB more_JJR TN_NNP than_IN do_VBP normal_RB fibroblasts_NNS [_NN
          15_CD 18_CD ]_NN ._. Because_IN cCAF_NN stimulates_NNS fibroblasts_NNS to_TO
          differentiate_VB into_IN myofibroblasts_NNS ,_, we_PRP tested_VBD the_DT
          possibility_NN that_IN this_DT chemokine_NN also_RB affects_VBZ TN_NNP
          production_NN ._. Immunolabeling_NNP of_IN cells_NNS treated_VBD daily_JJ for_IN
          four_CD days_NNS with_IN 750_CD ng_NN /_NN ml_NN of_IN the_DT chemokine_NN showed_VBD that_IN
          cCAF_NN stimulates_NNS the_DT cells_NNS to_TO produce_VB more_JJR TN_NNP than_IN the_DT
          control_NN cells_NNS (_( Fig_NNP ._. 1_LS A_DT &_CC 1_CD B_NNP )_) ._. We_PRP have_VBP previously_RB
          determined_VBN ,_, using_VBG dose-dependent_JJ studies_NNS ,_, that_IN this_DT
          concentration_NN is_VBZ optimal_NN for_IN functions_NNS of_IN this_DT chemokine_NN
          on_IN these_DT embryonic_JJ fibroblasts_NNS and_CC in_IN processes_NNS of_IN
          granulation_NN tissue_NN formation_NN [_NN 3_CD 4_CD ]_NN )_) ._. Although_IN
          chemokine_NN concentrations_NNS of_IN 10_CD -_: 2_CD -_: 10_CD ng_NN /_NN ml_NN can_MD
          chemoattract_NN and_CC activate_VBP leukocytes_NNS ,_, chemokines_NNS acting_VBG
          on_IN other_JJ cell_NN types_NNS such_JJ as_IN endothelial_NN cells_NNS ,_, smooth_JJ
          muscle_NN cells_NNS and_CC fibroblasts_NNS require_VBP concentrations_NNS in_IN
          the_DT range_NN of_IN 10_CD 2_CD ng_NN /_NN ml_NN and_CC higher_JJR [_NN 4_CD 26_CD 27_CD 28_CD ]_NN ._. This_DT
          is_VBZ within_IN physiological_JJ range_NN ;_: for_IN example_NN wound_VBD fluid_JJ
          from_IN burn_VB patients_NNS contain_VB MGSA_NNP (_( a_DT chemokine_NN that_WDT is_VBZ
          highly_RB homologous_RB to_TO cCAF_NN )_) concentrations_NNS of_IN 10_CD 2_CD -_: 10_CD
          3_CD ng_NN /_NN ml_NN [_NN 29_CD ]_NN ._. Because_IN both_DT the_DT N-_NNP terminal_NN and_CC
          C-_NNP terminal_NN peptides_NNS of_IN cCAF_NN have_VBP been_VBN shown_VBN to_TO be_VB
          functional_JJ in_IN culture_NN and_CC 
          in_IN vivo_NN (_( 1_CD -_: 4_CD ,_, 30_CD )_) ,_, we_PRP also_RB tested_VBD
          these_DT two_CD peptides_NNS (_( Fig_NNP ._. 1_LS )_) ._. The_DT N-_NNP terminal_NN 15_CD aa_NN peptide_NN
          produced_VBD an_DT effect_NN at_IN least_JJS as_RB strong_JJ as_IN the_DT whole_JJ
          molecule_NN (_( Fig_NNP ._. 1_LS C_NNP )_) whereas_IN the_DT effects_NNS of_IN the_DT C-_NNP terminal_NN
          peptide_NN (_( 28_CD aa_NN )_) was_VBD closer_JJR to_TO those_DT of_IN the_DT control_NN (_( Fig_NNP ._.
          1_LS D_NNP )_) ._. Western_JJ blot_NN analysis_NN of_IN extracts_NNS from_IN treated_VBN
          fibroblasts_NNS confirmed_VBD that_IN cCAF_NN increases_NNS production_NN of_IN
          TN_NNP in_IN culture_NN ,_, that_IN this_DT effect_NN also_RB can_MD be_VB accomplished_VBN
          effectively_RB by_IN the_DT N-_NNP peptide_NN ,_, but_CC that_IN the_DT C-_NNP peptide_NN
          produced_VBD an_DT elevated_VBD ,_, but_CC substantially_RB smaller_JJR ,_, response_NN
          than_IN either_DT the_DT N-_NNP peptide_NN or_CC the_DT whole_JJ cCAF_NN molecule_NN
          (_( Fig_NNP ._. 1_LS E_NNP )_) ._. To_TO determine_VB whether_IN cCAF_NN stimulates_NNS TN_NNP
          expression_NN we_PRP examined_VBD the_DT levels_NNS of_IN mRNA_NN for_IN this_DT ECM_NNP
          molecule_NN ._. RT-PCR_NNP analysis_NN showed_VBD significant_JJ increased_VBN
          levels_NNS of_IN mRNA_NN for_IN TN_NNP after_IN treatment_NN with_IN either_DT cCAF_NN or_CC
          its_PRP$ N-_NNP peptide_NN (_( Fig_NNP ._. 1_LS F_NN )_) but_CC the_DT increase_NN stimulated_VBN by_IN
          the_DT C-_NNP terminus_JJ is_VBZ much_RB smaller_JJR correlating_VBG with_IN the_DT small_JJ
          increase_NN in_IN protein_NN levels_NNS ._.
          To_TO determine_VB whether_IN this_DT effect_NN is_VBZ also_RB observed_VBN 
          in_IN vivo_NN ,_, excision_NN wounds_NNS were_VBD made_VBN
          on_IN the_DT underside_NN of_IN wings_NNS of_IN 2_CD week-old_JJ chicks_NNS ._. To_TO avoid_VB
          variations_NNS in_IN genetic_JJ background_NN ,_, for_IN each_DT bird_NN one_CD wing_NN
          was_VBD treated_VBN with_IN vehicle_NN and_CC the_DT other_JJ with_IN cCAF_NN ,_, and_CC
          treatments_NNS were_VBD applied_VBN every_DT other_JJ day_NN for_IN 5_CD days_NNS ._. In_IN
          normal_RB wound_VBD healing_VBG ,_, TN_NNP appeared_VBD at_IN days_NNS 2_CD -_: 3_CD and_CC
          disappeared_VBD during_IN remodeling_VBG which_WDT begins_VBZ around_IN day_NN 10_CD
          after_IN wounding_VBG ._. Therefore_RB ,_, tissues_NNS were_VBD collected_VBN at_IN days_NNS
          3_CD and_CC 7_CD after_IN wounding_VBG and_CC analyzed_VBD for_IN TN_NNP by_IN
          immunostaining_VBG and_CC western_JJ blot_NN analysis_NN (_( Fig_NNP ._. 2_LS A_DT &_CC
          2_CD B_NNP )_) ._. Immunoblot_NNP analysis_NN of_IN protein_NN extracted_VBN from_IN
          control_NN wounds_NNS confirmed_VBD that_IN TN_NNP deposition_NN begun_VBN by_IN 3_CD
          days_NNS and_CC that_IN it_PRP increased_VBN dramatically_RB by_IN 7_CD days_NNS (_( Fig_NNP ._.
          2_LS C_NNP ,_, Control_NNP )_) ._. In_IN contrast_NN ,_, by_IN 3_CD days_NNS ,_, cCAF-treated_JJ wounds_NNS
          already_RB contained_VBD as_IN much_RB TN_NNP as_IN the_DT control_NN at_IN 7_CD days_NNS and_CC
          that_IN by_IN 7_CD days_NNS ,_, the_DT TN_NNP is_VBZ dramatically_RB reduced_VBN by_IN the_DT
          ongoing_JJ processes_NNS of_IN repair_NN (_( Fig_NNP 2_CD C_NNP ,_, cCAF_NN )_) ._. Thus_RB ,_, the_DT
          addition_NN of_IN the_DT chemokine_NN to_TO wounds_NNS shifts_VBZ the_DT peak_NN of_IN TN_NNP
          in_IN the_DT wound_NN tissues_NNS to_TO earlier_JJR stages_NNS of_IN wound_VBD healing_VBG
          than_IN in_IN control_NN wounds_NNS ._.
        
        
          Effects_NNPS of_IN cCAF_NN and_CC its_PRP$ peptides_NNS on_IN the_DT production_NN
          of_IN FN_NNP
          Cellular_NNP FN_NNP is_VBZ abundantly_RB present_JJ in_IN granulation_NN
          tissue_NN ,_, is_VBZ produced_VBN primarily_RB by_IN the_DT wound_NN fibroblasts_NNS
          and_CC myofibroblasts_NNS ._. Fibroblast_NNP cultures_NNS treated_VBN as_IN for_IN
          TN_NNP ,_, produced_VBD much_RB more_JJR FN_NNP ,_, as_IN shown_VBN by_IN immunolabeling_VBG
          (_( Figs_NNP ._. 3_LS A_DT &_CC 3_CD B_NNP )_) and_CC immunoblot_NN analysis_NN (_( Fig_NNP ._. 3_LS E_NNP )_) ._.
          Unlike_IN TN_NNP ,_, this_DT effect_NN can_MD only_RB be_VB accomplished_VBN by_IN the_DT
          whole_JJ cCAF_NN molecule_NN ;_: immunolabeling_VBG and_CC immunoblot_NN
          analysis_NN of_IN cells_NNS treated_VBN with_IN the_DT N-_NNP peptide_NN (_( Fig_NNP ._.
          3_LS C_NNP &_CC 3_CD E_NNP )_) or_CC C-_NNP peptide_NN (_( Fig_NNP ._. 3_LS D_NNP &_CC 3_CD E_NNP )_) revealed_VBD
          similar_JJ FN_NNP levels_NNS to_TO control_VB ._. Unlike_IN TN_NNP ,_, cCAF_NN did_VBD not_RB
          affect_VB FN_NNP mRNA_NN levels_NNS (_( Fig_NNP ._. 3_LS F_NN )_) ._. 
          In_IN vivo_NN ,_, immunostaining_VBG for_IN FN_NNP ,_, 3_CD
          days_NNS after_IN making_VBG excision_NN wounds_NNS ,_, showed_VBD that_IN levels_NNS of_IN
          this_DT protein_NN are_VBP high_JJ in_IN the_DT healing_NN tissues_NNS and_CC that_DT
          treatment_NN with_IN cCAF_NN increased_VBD FN_NNP accumulation_NN in_IN the_DT
          granulation_NN tissue_NN (_( Fig_NNP ._. 4_LS A_DT &_CC 4_CD B_NNP )_) ._. Immunoblot_NNP analysis_NN
          for_IN FN_NNP extracted_VBD from_IN excision_NN wounds_NNS showed_VBD that_IN by_IN 3_CD
          days_NNS after_IN injury_NN the_DT cCAF-treated_JJ wounds_NNS contained_VBD more_JJR
          FN_NNP than_IN the_DT control_NN wounds_NNS but_CC that_IN the_DT levels_NNS by_IN 7_CD days_NNS
          are_VBP similar_JJ to_TO those_DT of_IN the_DT control_NN (_( Fig_NNP ._. 4_LS C_NNP )_) ._.
          Taken_VBN together_RB the_DT results_NNS in_IN culture_NN and_CC 
          in_IN vivo_NN suggest_VBP that_IN the_DT chemokine_NN
          does_VBZ not_RB stimulate_VB FN_NNP gene_NN expression_NN but_CC rather_RB may_MD
          directly_RB or_CC indirectly_RB affect_VB stability_NN of_IN this_DT protein_NN ._.
          Therefore_RB ,_, we_PRP tested_VBD the_DT possibility_NN that_DT cCAF_NN treatment_NN
          leads_VBZ to_TO stability_NN of_IN the_DT protein_NN by_IN stimulating_VBG decrease_NN
          in_IN matrix_NN degrading_JJ enzymes_NNS ._. In_IN chickens_NNS ,_, plasmin_NN
          generated_VBN from_IN plasminogen_NN by_IN plasminogen_NN activator_NN (_( PA_NNP )_)
          degrades_NNS much_JJ of_IN the_DT FN_NNP ._. To_TO investigate_VB whether_IN activity_NN
          of_IN PA_NNP might_MD be_VB decreased_VBN with_IN cCAF_NN treatment_NN leading_VBG to_TO
          accumulation_NN of_IN FN_NNP ,_, we_PRP examined_VBD the_DT levels_NNS of_IN PA_NNP
          activity_NN ._. Our_PRP$ results_NNS showed_VBD that_IN there_EX is_VBZ no_DT detectable_JJ
          PA_NNP activity_NN in_IN untreated_JJ or_CC treated_VBN fibroblasts_NNS whereas_IN
          the_DT activity_NN is_VBZ high_JJ in_IN RSV-transformed_NNP CEFs_NNP (_( tCEFs_NNS ;_: Fig_NNP ._.
          5_LS A_DT )_) which_WDT are_VBP known_VBN to_TO produce_VB high_JJ levels_NNS of_IN PA_NNP [_NN 31_CD ]_NN ._.
          Because_IN PA_NNP does_VBZ not_RB appear_VB to_TO be_VB activated_VBN by_IN cCAF_NN ,_, we_PRP
          tested_VBD the_DT possibility_NN that_IN the_DT stability_NN of_IN FN_NNP is_VBZ due_JJ to_TO
          a_DT decrease_NN in_IN MMP_NNP production_NN /_NN activation_NN ._. In_IN humans_NNS ,_,
          MMP-_NNP 3_CD ,_, MMP-_NNP 7_CD and_CC MMP-_NNP 10_CD (_( stromelysins_NNS )_) are_VBP the_DT most_RBS
          active_JJ proteases_NNS for_IN FN_NNP ,_, but_CC these_DT molecules_NNS have_VBP not_RB
          been_VBN isolated_VBN in_IN chickens_NNS ._. However_RB ,_, we_PRP can_MD test_VB for_IN
          general_JJ activity_NN of_IN these_DT MMPs_NNP in_IN the_DT chicken_NN system_NN by_IN
          zymography_NN using_VBG casein_NN as_IN substrate_NN (_( Fig_NNP ._. 5_LS B_NNP )_) ._. Whereas_IN
          the_DT positive_JJ control_NN (_( trypsin_NN )_) was_VBD able_JJ to_TO digest_VB the_DT
          substrate_NN at_IN specific_JJ sites_NNS in_IN the_DT gel_NN ,_, the_DT supernatants_NNS
          of_IN our_PRP$ treated_VBN fibroblasts_NNS did_VBD not_RB ._. This_DT suggests_VBZ that_IN
          the_DT stromelysins_NNS are_VBP not_RB active_JJ in_IN this_DT system_NN or_CC that_IN
          our_PRP$ test_NN is_VBZ not_RB sensitive_JJ enough_RB ._. To_TO further_VB investigate_VB
          whether_IN MMPs_NNP are_VBP involved_VBN in_IN the_DT cCAF_NN induced_VBD high_JJ levels_NNS
          of_IN FN_NNP will_MD require_VB evaluation_NN of_IN matrix-degrading_JJ enzymes_NNS
          specific_JJ for_IN chickens_NNS and_CC is_VBZ an_DT ongoing_JJ project_NN in_IN our_PRP$
          laboratory_NN as_IN we_PRP obtain_VBP /_NN develop_VB probes_NNS for_IN theses_NNS MMPs_NNP ._.
          However_RB ,_, another_DT possible_JJ mechanism_NN for_IN the_DT cCAF-induced_JJ
          FN_NNP accumulation_NN could_MD be_VB linked_VBN to_TO an_DT increase_NN in_IN TN_NNP ._.
          TN-C_NNP knockout_NN mice_NNS show_NN decreased_VBD accumulation_NN of_IN FN_NNP in_IN
          wounded_VBN tissue_NN and_CC this_DT decrease_NN has_VBZ been_VBN hypothesized_VBN to_TO
          be_VB due_JJ to_TO disrupted_VBN incorporation_NN of_IN FN_NNP into_IN the_DT matrix_NN
          in_IN the_DT absence_NN of_IN TN-C_NNP [_NN 32_CD 33_CD ]_NN ._. To_TO determine_VB whether_IN
          cCAF-induced_JJ TN_NNP production_NN is_VBZ involved_VBN in_IN the_DT increase_NN in_IN
          FN_NNP observed_VBD after_IN cCAF_NN treatment_NN ,_, we_PRP used_VBD antisense_NN
          phosphothioated_JJ oligonucleotides_NNS to_TO inhibit_VB TN_NNP
          production_NN ._. Sense_NN oligonucleotides_NNS did_VBD not_RB have_VB an_DT effect_NN
          on_IN cCAF-induced_JJ TN_NNP or_CC FN_NNP production_NN ._. However_RB ,_, the_DT
          antisense_NN oligonucleotides_NNS were_VBD able_JJ to_TO significantly_RB
          decrease_VB the_DT production_NN of_IN both_DT TN_NNP and_CC FN_NNP (_( Fig_NNP ._. 5_LS C_NNP )_) ._.
        
        
          Effects_NNPS of_IN cCAF_NN and_CC its_PRP$ peptides_NNS on_IN the_DT production_NN
          of_IN Colls_NNP I_PRP and_CC III_NNP
          To_TO determine_VB whether_IN cCAF_NN stimulates_NNS fibroblasts_NNS to_TO
          produce_VB increased_VBN levels_NNS of_IN Colls_NNP I_PRP and_CC III_NNP ,_, we_PRP treated_VBD
          cultures_NNS as_IN for_IN TN_NNP ._. Immunoblot_NNP analysis_NN for_IN Coll_NNP I_PRP showed_VBD
          that_DT cCAF_NN ,_, but_CC not_RB the_DT N-_NNP or_CC C-_NNP peptides_NNS ,_, caused_VBD a_DT small_JJ
          increase_NN in_IN Coll_NNP I_PRP protein_NN levels_NNS (_( Fig_NNP ._. 6_CD A_DT )_) ._. Probing_VBG the_DT
          same_JJ blots_NNS for_IN Coll_NNP III_NNP revealed_VBD no_DT cCAF-induced_JJ
          difference_NN in_IN the_DT level_NN of_IN production_NN of_IN this_DT protein_NN
          (_( Fig_NNP ._. 6_CD B_NNP )_) ._. 
          In_IN vivo_NN ,_, Coll_NNP I_PRP was_VBD also_RB slightly_RB
          increased_VBN by_IN treatment_NN with_IN the_DT chemokine_NN at_IN 3_CD days_NNS after_IN
          wounding_VBG but_CC did_VBD not_RB increase_VB to_TO higher_JJR levels_NNS than_IN the_DT
          control_NN at_IN 7_CD days_NNS ,_, whereas_IN the_DT same_JJ blots_NNS probed_JJ for_IN Coll_NNP
          III_NNP showed_VBD similar_JJ levels_NNS in_IN treated_VBN and_CC control_NN at_IN both_DT
          3_CD and_CC 7_CD days_NNS (_( Figure_NN 6_CD C_NNP )_) ._.
          The_DT effect_NN on_IN Coll_NNP I_PRP could_MD be_VB due_JJ to_TO remodeling_NN of_IN
          this_DT protein_NN by_IN proteases_NNS induced_VBN by_IN the_DT chemokine_NN ._.
          Therefore_RB ,_, we_PRP tested_VBD whether_IN cCAF_NN affects_VBZ the_DT production_NN
          or_CC activity_NN of_IN the_DT gelatinases_NNS MMP-_NNP 2_CD or_CC MMP-_NNP 9_CD ,_, or_CC the_DT
          collagenase_NN MMP-_NNP 1_CD ,_, all_DT of_IN which_WDT digest_VB collagens_NNS I_PRP and_CC
          III_NNP ._. Using_VBG zymography_NN ,_, we_PRP found_VBD that_DT treatment_NN with_IN cCAF_NN
          or_CC the_DT peptides_NNS does_VBZ not_RB alter_VB the_DT levels_NNS of_IN proMMP-_NN 2_CD and_CC
          there_EX was_VBD no_DT detectable_JJ levels_NNS of_IN proMMP-_NN 9_CD (_( Fig_NNP ._. 7_CD A_DT )_) ._.
          However_RB ,_, immunoblot_NN analysis_NN using_VBG a_DT polyclonal_NN antibody_NN
          to_TO human_JJ MMP-_NNP 1_CD (_( this_DT reagent_NN is_VBZ not_RB available_JJ for_IN the_DT
          chicken_NN homologue_NN of_IN this_DT matrix_NN metalloproteinase_NN )_)
          showed_VBD that_DT cCAF_NN treatment_NN caused_VBD a_DT decrease_NN in_IN the_DT
          amount_NN of_IN the_DT collagenase_NN MMP-_NNP 1_CD detected_VBD ,_, but_CC neither_DT
          TIMP-_NNP 1_CD nor_CC TIMP-_NNP 2_CD (_( two_CD natural_JJ inhibitors_NNS of_IN these_DT MMPs_NNP )_)
          levels_NNS were_VBD changed_VBN ,_, as_IN evaluated_VBN by_IN immunoblot_NN analysis_NN
          with_IN a_DT monoclonal_NN antibody_NN to_TO the_DT corresponding_JJ human_JJ
          proteins_NNS (_( Fig_NNP ._. 7_CD B_NNP )_) ._.
        
        
          Effects_NNPS of_IN cCAF_NN on_IN migration_NN of_IN fibroblasts_NNS
          During_IN healing_NN ,_, fibroblasts_NNS migrate_VB into_IN and_CC within_IN
          the_DT wounded_VBN tissue_NN and_CC lay_VB down_RP the_DT extracellular_NN matrix_NN
          that_IN forms_VBZ the_DT granulation_NN tissue_NN ._. These_DT ECM_NNP molecules_NNS ,_,
          especially_RB TN_NNP and_CC FN_NNP together_RB ,_, stimulate_VB cell_NN migration_NN ,_,
          thereby_RB facilitating_VBG the_DT entrance_NN and_CC movement_NN of_IN
          additional_JJ fibroblasts_NNS and_CC of_IN endothelial_NN cells_NNS into_IN the_DT
          wound_NN tissue_NN ._. Because_IN tissues_NNS treated_VBN with_IN cCAF_NN have_VBP more_JJR
          FN_NNP and_CC TN_NNP at_IN the_DT time_NN that_IN these_DT cells_NNS are_VBP entering_VBG the_DT
          wound_NN and_CC chemokines_NNS are_VBP well_RB known_VBN for_IN their_PRP$
          chemoattractant_NN properties_NNS [_NN 34_CD 35_CD ]_NN ,_, we_PRP tested_VBD whether_IN
          cCAF_NN stimulates_NNS chemotaxis_NNS of_IN fibroblasts_NNS using_VBG transwell_NN
          assays_NNS ._. To_TO avoid_VB effects_NNS of_IN gravity_NN on_IN cell_NN migration_NN ,_,
          the_DT top_JJ chamber_NN was_VBD inverted_JJ ,_, the_DT cells_NNS were_VBD plated_JJ on_IN
          the_DT underside_NN of_IN the_DT membrane_NN ,_, allowed_VBN to_TO adhere_VB to_TO it_PRP
          and_CC then_RB the_DT chamber_NN was_VBD turned_VBN right_JJ side_NN up_RB ._. The_DT cells_NNS
          were_VBD incubated_JJ overnight_JJ in_IN standard_JJ medium_NN to_TO allow_VB
          expression_NN of_IN the_DT cCAF_NN receptor_NN (_( s_VBZ )_) and_CC the_DT following_VBG day_NN
          cCAF_NN was_VBD applied_VBN at_IN increasing_VBG doses_NNS (_( 100_CD -_: 1000_CD ng_NN /_NN ml_NN )_) to_TO
          the_DT top_JJ chamber_NN only_RB ._. The_DT migration_NN assays_NNS were_VBD carried_VBN
          out_IN for_IN 24_CD hrs_NNS ._. We_PRP found_VBD that_DT cCAF_NN stimulated_VBN migration_NN
          of_IN the_DT fibroblasts_NNS up_RP the_DT concentration_NN gradient_NN in_IN a_DT
          dose-dependent_JJ manner_NN (_( Fig_NNP ._. 8_CD A_DT )_) ._. To_TO test_VB whether_IN the_DT
          cCAF-induced_JJ effect_NN is_VBZ due_JJ to_TO chemotaxis_NNS ,_, we_PRP repeated_VBD the_DT
          transwell_NN assay_NN and_CC compared_VBN cell_NN migration_NN when_WRB cCAF_NN is_VBZ
          added_VBN to_TO both_DT wells_NNS ._. Placing_NNP cCAF_NN in_IN both_DT wells_NNS abrogated_JJ
          cell_NN migration_NN ,_, strongly_RB suggesting_VBG that_IN this_DT protein_NN
          chemoattracts_NNS fibroblasts_NNS (_( Fig_NNP 8_CD B_NNP )_) ._. We_PRP also_RB tested_VBD the_DT
          effects_NNS of_IN the_DT chemokine_NN on_IN migration_NN by_IN using_VBG the_DT
          cloning_VBG ring_NN assay_NN ._. In_IN a_DT specified_VBN length_NN of_IN time_NN ,_, cells_NNS
          treated_VBN with_IN cCAF_NN moved_VBD a_DT longer_JJR distance_NN than_IN did_VBD
          control_NN cells_NNS ,_, corroborating_VBG the_DT previous_JJ results_NNS that_IN
          the_DT chemokine_NN stimulates_NNS cell_NN motility_NN (_( Fig_NNP ._. 8_CD C_NNP )_) ._. 
          In_IN situ_NN hybridization_NN for_IN cCAF_NN
          showed_VBD that_IN the_DT migrating_VBG fibroblasts_NNS also_RB express_VBP higher_JJR
          levels_NNS of_IN cCAF_NN (_( Fig_NNP ._. 8_CD D_NNP &_CC 8_CD E_NNP ;_: see_VB also_RB ref_NN ._. [_NN 36_CD ]_NN
          )_) ._.
        
      
      
        Discussion_NNP
        The_DT work_NN presented_VBN here_RB shows_VBZ that_DT cCAF_NN ,_, the_DT IL-_NNP 8_CD of_IN
        chickens_NNS ,_, stimulates_NNS expression_NN of_IN several_JJ ECM_NNP molecules_NNS
        important_JJ in_IN development_NN of_IN the_DT granulation_NN tissue_NN ._. We_PRP show_VBP
        that_IN :_: 
        (_( i_NNP )_) cCAF_NN stimulates_NNS TN_NNP expression_NN and_CC
        that_IN a_DT 15_CD aa_NN peptide_NN containing_VBG the_DT N-_NNP terminal_NN sequence_NN
        causes_VBZ the_DT same_JJ effects_NNS as_IN the_DT whole_JJ molecule_NN ;_: 
        (_( ii_NN )_) in_IN contrast_NN to_TO its_PRP$ effects_NNS on_IN TN_NNP
        production_NN ,_, cCAF-induced_JJ increase_NN in_IN FN_NNP and_CC Coll_NNP I_PRP
        accumulation_NN requires_VBZ the_DT whole_JJ molecule_NN ;_: 
        (_( iii_NN )_) the_DT increase_NN in_IN FN_NNP protein_NN is_VBZ not_RB
        a_DT result_NN of_IN a_DT corresponding_JJ increase_NN in_IN mRNA_NN ,_, or_CC increase_NN
        in_IN MMP_NNP production_NN or_CC PA_NNP activity_NN but_CC appears_VBZ to_TO be_VB linked_VBN
        TN_NNP production_NN ;_: 
        (_( iv_NN )_) increase_NN in_IN Coll_NNP I_PRP correlates_NNS with_IN
        decreased_VBD levels_NNS of_IN MMP-_NNP 1_CD ;_: 
        (_( v_NN )_) cCAF_NN chemoattracts_NNS fibroblasts_NNS and_CC
        accelerates_VBZ their_PRP$ migration_NN ;_: 
        (_( vi_NN )_) treatment_NN of_IN excision_NN wounds_NNS with_IN
        cCAF_NN increased_VBD the_DT levels_NNS of_IN all_DT three_CD ECM_NNP molecules_NNS in_IN the_DT
        granulation_NN tissue_NN of_IN wounds_NNS albeit_IN with_IN different_JJ
        dynamics_NNS ._. This_DT is_VBZ the_DT first_JJ demonstration_NN that_DT treatment_NN of_IN
        wounds_NNS with_IN a_DT pro-inflammatory_JJ and_CC angiogenic_JJ chemokine_NN
        accelerates_VBZ development_NN of_IN the_DT granulation_NN tissue_NN during_IN
        healing_NN by_IN stimulating_VBG the_DT precocious_JJ deposition_NN of_IN ECM_NNP
        molecules_NNS that_WDT are_VBP critical_JJ for_IN proper_JJ healing_NN ._.
        We_PRP showed_VBD previously_RB that_DT cCAF_NN is_VBZ highly_RB expressed_VBN in_IN
        the_DT granulation_NN tissue_NN of_IN wounds_NNS [_NN 6_CD 36_CD ]_NN ,_, that_IN this_DT
        chemokine_NN and_CC several_JJ of_IN its_PRP$ human_JJ homologues_NNS stimulate_VB
        differentiation_NN of_IN fibroblasts_NNS into_IN myofibroblasts_NNS both_DT in_IN
        culture_NN and_CC 
        in_IN vivo_NN ,_, and_CC that_IN the_DT latter_JJ effect_NN
        can_MD be_VB achieved_VBN very_RB effectively_RB by_IN the_DT N-_NNP terminal_NN 15_CD aas_NNS of_IN
        the_DT protein_NN [_NN 4_CD 37_CD ]_NN ._. In_IN addition_NN to_TO cCAF_NN ,_, other_JJ CXC_NNP
        chemokines_NNS have_VBP been_VBN associated_VBN with_IN wound_VBD healing_VBG events_NNS ._.
        In_IN the_DT granulation_NN tissue_NN of_IN burn_VB wounds_NNS ,_, expression_NN of_IN
        groα_NN /_NN MGSA_NNP and_CC CXCR_NNP 2_CD (_( the_DT receptor_NN for_IN MGSA_NNP )_) was_VBD associated_VBN
        with_IN fibroblasts_NNS ,_, smooth_JJ muscle_NN cells_NNS /_NN myofibroblasts_NNS and_CC a_DT
        subpopulation_NN of_IN macrophages_NNS [_NN 7_CD ]_NN ._. Groα_NNP /_NN MGSA_NNP and_CC IL-_NNP 8_CD
        have_VBP also_RB been_VBN shown_VBN to_TO enhance_VB re-epithelialization_JJ of_IN
        human_JJ skin_NN grafts_NNS in_IN chimeric_JJ mice_NNS [_NN 29_CD 38_CD ]_NN ._. It_PRP has_VBZ also_RB
        been_VBN found_VBN that_IN several_JJ CXC_NNP chemokines_NNS can_MD modulate_VBP
        angiogenesis_NNS [_NN 39_CD ]_NN ,_, a_DT process_NN that_WDT is_VBZ critical_JJ for_IN proper_JJ
        healing_NN ._. Some_DT CXC_NNP chemokines_NNS ,_, such_JJ as_IN IL-_NNP 8_CD and_CC cCAF_NN ,_, are_VBP
        angiogenic_JJ 
        in_IN vivo_NN [_NN 3_CD 39_CD 40_CD 41_CD ]_NN ._. Others_NNS ,_, such_JJ
        as_IN IP-_NNP 10_CD (_( interferon-γ_JJ 10_CD )_) and_CC PF-_NNP 4_CD (_( platelet_NN factor-_NN 4_LS )_) ,_, are_VBP
        anti-angiogenic_JJ ._. In_IN the_DT case_NN of_IN IP-_NNP 10_CD ,_, it_PRP has_VBZ been_VBN shown_VBN
        that_IN in_IN transgenic_JJ mice_NNS treated_VBN with_IN this_DT chemokine_NN ,_, wounds_NNS
        heal_VB poorly_RB and_CC exhibit_NN defects_NNS in_IN angiogenesis_NNS and_CC
        development_NN of_IN the_DT granulation_NN tissue_NN [_NN 8_CD ]_NN ._.
        Work_NN of_IN others_NNS has_VBZ shown_VBN that_IN TN_NNP is_VBZ expressed_VBN in_IN
        association_NN with_IN differentiation_NN of_IN myofibroblasts_NNS and_CC is_VBZ
        important_JJ in_IN cell_NN migration_NN during_IN healing_NN [_NN 25_CD 42_CD 43_CD 44_CD ]_NN
        ._. Here_RB we_PRP show_VBP that_DT cCAF_NN and_CC the_DT N-_NNP peptide_NN stimulate_VB
        fibroblasts_NNS in_IN culture_NN to_TO express_VB TN_NNP and_CC that_IN this_DT increase_NN
        in_IN TN_NNP is_VBZ due_JJ to_TO an_DT increase_NN in_IN mRNA_NN levels_NNS ._. The_DT increase_NN is_VBZ
        lower_JJR for_IN C-_NNP peptide_NN treated_VBD cells_NNS ;_: after_IN 3_CD days_NNS in_IN an_DT
        environment_NN mimicking_VBG the_DT wound_NN ,_, these_DT cells_NNS had_VBD lesser_JJR but_CC
        significant_JJ tenascin_NN protein_NN levels_NNS ,_, most_RBS likely_JJ due_NN to_TO the_DT
        small_JJ increase_NN seen_VBN in_IN mRNA_NN ._. In_IN addition_NN ,_, in_IN wounds_NNS treated_VBN
        with_IN the_DT chemokine_NN ,_, TN_NNP levels_NNS are_VBP much_RB higher_JJR at_IN early_JJ
        times_NNS after_IN wounding_VBG but_CC drop_NN by_IN 7_CD days_NNS after_IN wounding_VBG ._. At_IN
        this_DT stage_NN ,_, the_DT wounds_NNS are_VBP closed_VBN and_CC are_VBP beginning_VBG to_TO
        remodel_NN in_IN the_DT cCAF-treated_JJ wounds_NNS while_IN the_DT granulation_NN
        tissue_NN in_IN the_DT control_NN wings_NNS is_VBZ still_RB maturing_VBG ._. These_DT data_NNS
        taken_VBN together_RB strongly_RB suggest_VBP that_IN as_IN chemokines_NNS induce_VB
        the_DT differentiation_NN of_IN fibroblasts_NNS into_IN myofibroblasts_NNS they_PRP
        contribute_VBP to_TO the_DT production_NN of_IN TN_NNP in_IN the_DT granulation_NN
        tissue_NN ._. Our_PRP$ finding_VBG that_IN the_DT N-_NNP terminal_NN peptide_NN is_VBZ able_JJ to_TO
        stimulate_VB expression_NN of_IN TN_NNP much_JJ like_IN the_DT whole_JJ protein_NN is_VBZ
        potentially_RB important_JJ because_IN this_DT small_JJ peptide_NN may_MD be_VB
        useful_JJ to_TO develop_VB therapeutic_JJ agonists_NNS or_CC antagonists_NNS for_IN
        wound_VBD healing_VBG ._.
        The_DT effect_NN of_IN cCAF_NN treatment_NN on_IN Coll_NNP I_PRP accumulation_NN in_IN
        culture_NN and_CC in_IN wounded_VBN tissues_NNS is_VBZ small_JJ but_CC reproducible_JJ ._.
        Because_IN MMP-_NNP 1_CD levels_NNS were_VBD also_RB decreased_VBN by_IN cCAF_NN treatment_NN ,_,
        it_PRP is_VBZ possible_JJ that_IN the_DT small_JJ rise_NN in_IN Coll_NNP I_PRP levels_NNS is_VBZ due_JJ
        to_TO decreased_VBD degradation_NN of_IN this_DT ECM_NNP molecule_NN by_IN the_DT
        collagenase_NN ._. Another_DT chemokine_NN that_WDT has_VBZ been_VBN associated_VBN
        with_IN Coll_NNP I_PRP production_NN is_VBZ monocyte_NN chemotactic_JJ protein_NN 1_CD
        (_( MCP-_NNP 1_LS )_) ._. This_DT chemokine_NN belongs_VBZ to_TO the_DT CC_NNP chemokine_NN family_NN
        and_CC stimulates_NNS Coll_NNP I_PRP production_NN both_DT by_IN lung_NN fibroblasts_NNS
        taken_VBN from_IN areas_NNS of_IN inflammation_NN [_NN 26_CD ]_NN and_CC in_IN kidneys_NNS that_WDT
        suffer_VBP from_IN crescentic_JJ nephritis_NNS [_NN 45_CD ]_NN ._. The_DT former_JJ
        investigators_NNS reported_VBD that_IN MCP-_NNP 1_CD increases_NNS collagen_NN
        accumulation_NN not_RB by_IN decreasing_VBG the_DT levels_NNS of_IN the_DT
        collagenase_NN MMP-_NNP 1_CD ,_, but_CC by_IN stimulating_VBG the_DT production_NN of_IN
        TGFβ_NNP 1_CD ,_, a_DT well-known_JJ stimulator_NN of_IN collagen_NN expression_NN and_CC
        expression_NN of_IN TIMPs_NNP ,_, the_DT natural_JJ inhibitors_NNS of_IN MMPs_NNP ._. In_IN
        addition_NN to_TO MCP-_NNP 1_CD ,_, IL-_NNP 8_CD and_CC MGSA_NNP have_VBP also_RB been_VBN evaluated_VBN
        for_IN production_NN of_IN collagen_NN [_NN 46_CD ]_NN ._. These_DT investigators_NNS
        reported_VBD that_DT treatment_NN of_IN normal_JJ fibroblasts_NNS with_IN these_DT
        chemokines_NNS did_VBD not_RB affect_VB collagen_NN levels_NNS ._. It_PRP is_VBZ not_RB clear_JJ
        from_IN their_PRP$ results_NNS whether_IN the_DT elevation_NN in_IN collagen_NN
        production_NN in_IN normal_JJ fibroblasts_NNS may_MD have_VB been_VBN small_JJ ,_, like_IN
        that_DT observed_VBD with_IN cCAF_NN ,_, and_CC therefore_RB gone_VBN unnoticed_JJ ._.
        FN_NNP accumulation_NN due_JJ to_TO cCAF_NN treatment_NN also_RB differs_VBZ from_IN
        that_DT of_IN TN_NNP ._. The_DT FN_NNP mRNA_NN levels_NNS are_VBP not_RB affected_VBN by_IN cCAF_NN
        treatment_NN but_CC the_DT protein_NN accumulates_NNS in_IN culture_NN and_CC in_IN the_DT
        granulation_NN tissue_NN of_IN wounds_NNS upon_IN exposure_NN to_TO the_DT
        chemokine_NN ._. By_IN analogy_NN with_IN the_DT increase_NN in_IN Coll_NNP I_PRP ,_, we_PRP
        hypothesized_VBN that_WDT decrease_VBP in_IN protease_NN levels_NNS /_NN activity_NN is_VBZ
        involved_VBN in_IN the_DT accumulation_NN of_IN FN_NNP ._. Plasmin_NNP resulting_VBG from_IN
        cleavage_NN of_IN plasminogen_NN by_IN plasminogen_NN activator_NN (_( PA_NNP )_) is_VBZ
        the_DT major_JJ enzyme_NN affecting_VBG FN_NNP degradation_NN in_IN chickens_NNS ._.
        However_RB ,_, testing_NN for_IN decrease_NN in_IN PA_NNP activity_NN showed_VBD that_IN
        this_DT enzyme_NN is_VBZ not_RB activated_VBN even_RB in_IN the_DT controls_NNS ,_,
        therefore_RB ,_, it_PRP is_VBZ unlikely_JJ that_IN this_DT would_MD be_VB a_DT major_JJ
        mechanism_NN involved_VBN in_IN degrading_JJ FN_NNP ._. In_IN humans_NNS ,_, there_EX are_VBP
        several_JJ MMPs_NNP that_WDT are_VBP known_VBN to_TO degrade_NN FN_NNP ._. We_PRP found_VBD that_IN
        MMP-_NNP 2_CD levels_NNS are_VBP unaffected_JJ by_IN cCAF_NN treatment_NN and_CC that_IN
        there_EX is_VBZ no_DT detectable_JJ MMP-_NNP 3_CD ,_, -_: 7_CD and_CC -_: 10_CD activity_NN as_IN
        evaluated_VBN by_IN casein_NN zymography_NN using_VBG tCEFs_NNS as_IN control_NN for_IN
        production_NN of_IN these_DT stromelysins_NNS ._. Another_DT FN-degrading_NNP
        metalloproteinase_NN ,_, MT-MMP_NNP 1_CD ,_, is_VBZ unlikely_JJ to_TO be_VB involved_VBN
        because_IN it_PRP also_RB activates_NNS MMP-_NNP 2_CD and_CC this_DT enzyme_NN is_VBZ not_RB
        activated_VBN by_IN cCAF_NN treatment_NN ._.
        Another_DT possible_JJ mechanism_NN that_WDT may_MD explain_VB FN_NNP
        accumulation_NN could_MD be_VB an_DT increase_NN in_IN TN_NNP ._. TN-C_NNP knockout_NN mice_NNS
        show_NN decreased_VBD accumulation_NN of_IN FN_NNP in_IN wounded_VBN tissue_NN and_CC
        this_DT decrease_NN has_VBZ been_VBN hypothesized_VBN to_TO be_VB due_JJ to_TO disrupted_VBN
        incorporation_NN on_IN FN_NNP into_IN the_DT matrix_NN in_IN the_DT absence_NN of_IN TN-C_NNP
        [_NN 32_CD 33_CD ]_NN ._. Therefore_RB ,_, our_PRP$ observation_NN that_DT inhibition_NN of_IN
        cCAF-induced_JJ TN_NNP production_NN decreases_VBZ the_DT accumulation_NN of_IN FN_NNP
        supports_VBZ the_DT findings_NNS in_IN the_DT knockout_NN mice_NNS ._. However_RB ,_, this_DT
        does_VBZ not_RB explain_VB the_DT unchanged_JJ FN_NNP levels_NNS with_IN the_DT N-_NNP peptide_NN
        treatment_NN ._. One_CD possible_JJ explanation_NN for_IN these_DT findings_NNS
        could_MD relate_VB to_TO the_DT fact_NN that_IN FN_NNP does_VBZ not_RB self-assemble_JJ ._.
        Therefore_RB ,_, it_PRP is_VBZ possible_JJ that_IN alterations_NNS in_IN the_DT
        activities_NNS of_IN integrins_NNS or_CC adhesive_NN sites_NNS on_IN other_JJ ECM_NNP
        molecules_NNS induced_VBN by_IN the_DT whole_JJ cCAF_NN molecule_NN ,_, and_CC not_RB by_IN
        the_DT N-_NNP peptide_NN ,_, could_MD affect_VB FN_NNP accumulation_NN [_NN 47_CD ]_NN ._. We_PRP are_VBP
        currently_RB pursuing_VBG studies_NNS to_TO determine_VB whether_IN adhesion_NN
        molecules_NNS or_CC other_JJ ECM_NNP molecules_NNS play_VBP a_DT role_NN in_IN FN_NNP
        accumulation_NN due_JJ to_TO cCAF-induced_JJ TN_NNP production_NN ._.
        Migration_NNP of_IN fibroblasts_NNS from_IN the_DT area_NN surrounding_VBG the_DT
        wound_NN into_IN the_DT wound_NN site_NN is_VBZ critical_JJ in_IN order_NN for_IN
        remodeling_NN of_IN the_DT extracellular_NN matrix_NN and_CC for_IN wound_VBD
        contraction_NN to_TO occur_VB ._. TN_NNP and_CC FN_NNP ,_, especially_RB in_IN combination_NN ,_,
        promote_VB migration_NN ,_, therefore_RB cCAF_NN may_MD facilitate_VB fibroblast_NN
        migration_NN by_IN increasing_VBG TN_NNP and_CC FN_NNP levels_NNS ._. However_RB ,_, this_DT
        chemokine_NN is_VBZ also_RB able_JJ to_TO chemoattract_NN fibroblasts_NNS and_CC
        accelerate_VB their_PRP$ migration_NN in_IN the_DT absence_NN of_IN these_DT
        molecules_NNS ,_, strongly_RB suggesting_VBG that_IN it_PRP contributes_VBZ to_TO
        fibroblast_NN movement_NN independently_RB of_IN the_DT deposition_NN of_IN
        these_DT ECM_NNP molecule_NN ._. These_DT findings_NNS suggest_VBP that_IN during_IN
        wound_VBD healing_VBG ,_, cCAF_NN produced_VBN by_IN the_DT resident_NN fibroblasts_NNS
        chemoattracts_NNS additional_JJ fibroblasts_NNS that_WDT contribute_VBP to_TO the_DT
        production_NN of_IN these_DT ECM_NNP molecules_NNS ,_, which_WDT then_RB support_NN
        migration_NN of_IN both_DT fibroblasts_NNS and_CC other_JJ cells_NNS in_IN the_DT wound_NN
        tissue_NN ._.
        TGFβ_NNP 1_CD is_VBZ another_DT factor_NN known_VBN to_TO stimulate_VB myofibroblast_NN
        differentiation_NN ,_, ECM_NNP production_NN and_CC accelerate_VB wound_VBD
        closure_NN and_CC healing_NN ._. However_RB ,_, this_DT growth_NN factor_NN has_VBZ a_DT
        strong_JJ inflammatory_JJ effect_NN that_WDT leads_VBZ to_TO excess_JJ fibrosis_NNS
        and_CC scarring_VBG ._. In_IN addition_NN to_TO greatly_RB increasing_VBG
        accumulation_NN of_IN Colls_NNP I_PRP and_CC III_NNP ,_, TGFβ_NNP 1_CD has_VBZ been_VBN shown_VBN to_TO
        also_RB increase_VB FN_NNP and_CC TN_NNP production_NN ._. cCAF_NN (_( and_CC maybe_RB other_JJ
        chemokines_NNS )_) ,_, on_IN the_DT other_JJ hand_NN ,_, may_MD have_VB a_DT subtler_NN ,_, more_RBR
        controlled_JJ effect_NN ,_, promoting_VBG the_DT earlier_JJR appearance_NN of_IN a_DT
        normal_JJ granulation_NN tissue_NN without_IN leading_VBG to_TO excess_JJ matrix_NN
        accumulation_NN and_CC scarring_VBG ._.
      
      
        Conclusions_NNP
        Our_PRP$ results_NNS strongly_RB suggest_VBP that_DT cCAF_NN plays_VBZ an_DT
        important_JJ role_NN in_IN wound_VBD repair_NN by_IN activating_VBG fibroblasts_NNS to_TO
        form_VB early_JJ granulation_NN tissue_NN ,_, through_IN cell_NN migration_NN ,_,
        myofibroblast_NN differentiation_NN and_CC production_NN /_NN accumulation_NN
        of_IN ECM_NNP molecules_NNS that_WDT are_VBP critical_JJ for_IN proper_JJ development_NN
        of_IN the_DT healing_NN tissue_NN of_IN wounds_NNS ._. This_DT is_VBZ a_DT previously_RB
        unknown_JJ role_NN for_IN chemokines_NNS and_CC ,_, unlike_IN other_JJ inflammatory_JJ
        factors_NNS that_WDT promote_VBP granulation_NN tissue_NN formation_NN ,_, cCAF_NN
        does_VBZ not_RB appear_VB to_TO stimulate_VB increased_VBN fibrosis_NNS ._. If_IN similar_JJ
        behavior_NN is_VBZ seen_VBN in_IN human_JJ chemokines_NNS ,_, it_PRP could_MD be_VB a_DT
        promising_JJ target_NN in_IN designing_VBG drugs_NNS that_WDT promote_VBP formation_NN
        of_IN granulation_NN tissue_NN in_IN poorly_RB healing_VBG wounds_NNS without_IN
        causing_VBG excess_JJ scarring_VBG ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Reagents_NNP
          All_DT tissue_NN culture_NN supplies_NNS and_CC the_DT TRIzol_NNP reagent_NN
          were_VBD purchased_VBN from_IN Gibco-_NNP BRL_NNP ._. cCAF_NN and_CC the_DT N-_NNP terminal_NN
          peptide_NN (_( 15_CD a_DT ._. a_DT ._. )_) were_VBD synthesized_JJ by_IN Gryphon_NNP Sciences_NNPS
          (_( San_NNP Francisco_NNP ,_, CA_NNP )_) and_CC C-_NNP terminus_JJ peptide_NN (_( 28_CD a_DT ._. a_DT )_) was_VBD
          made_VBN by_IN Milligen_NNP Biosearch_NNP (_( San_NNP Rafael_NNP ,_, CA_NNP )_) ._. Secondary_JJ
          antibodies_NNS used_VBN :_: anti-mouse_JJ and_CC anti-rabbit_JJ horseradish_NN
          peroxidase_NN ,_, anti-mouse_JJ Texas_NNP Red_NNP (_( Amersham_NNP :_: Piscataway_NNP ,_,
          NJ_NNP )_) and_CC anti-mouse_JJ FITC_NNP (_( DAKO_NNP :_: Carpinteria_NNP ,_, CA_NNP )_) ._. Primary_JJ
          antibodies_NNS used_VBN :_: mouse_NN anti-chicken_JJ Coll_NNP I_PRP ,_, Coll_NNP III_NNP ,_, FN_NNP ,_,
          and_CC TN_NNP (_( Hybridoma_NNP Bank_NNP ,_, Iowa_NNP )_) ,_, rabbit_NN anti-chicken_JJ TN_NNP
          (_( Chemicon_NNP ,_, Temecula_NNP CA_NNP )_) ._. Rabbit_NNP anti-human_JJ MMP-_NNP 1_CD and_CC
          TIMP-_NNP 2_CD and_CC mouse_NN anti-human_JJ TIMP-_NNP 1_CD were_VBD the_DT kind_NN gift_NN of_IN
          Dr_NNP ._. Tai-_NNP Lan_NNP Tuan_NNP ._. The_DT ECL_NNP reagents_NNS were_VBD purchased_VBN from_IN
          Amersham_NNP ;_: Vectashield_NNP mounting_VBG medium_NN from_IN Vector_NNP
          Laboratories_NNPS (_( Burlingame_NNP ,_, CA_NNP )_) ;_: DC_NNP protein_NN assay_NN kit_NN from_IN
          Bio-_NNP Rad_NNP (_( Hercules_NNP ,_, CA_NNP )_) ;_: Biocoat_NNP and_CC Transwells_NNP from_IN
          Fisher_NNP and_CC Biocclusive_NNP bandage_NN from_IN Johnson_NNP &_CC Johnson_NNP
          Medical_NNP (_( Arlington_NNP ,_, TX_NNP )_) ._.
        
        
          Cell_NNP culture_NN
          Primary_JJ chicken_NN embryonic_JJ fibroblasts_NNS were_VBD cultured_JJ as_IN
          previously_RB described_VBD [_NN 3_CD 4_CD ]_NN ._. Briefly_NNP ,_, primary_JJ
          fibroblasts_NNS were_VBD isolated_VBN from_IN 10_CD -_: day-old_JJ chicken_NN embryos_NNS
          and_CC cultured_JJ for_IN 4_CD days_NNS ._. These_DT cultures_NNS were_VBD passaged_JJ
          once_RB and_CC used_VBN as_IN secondary_JJ cultures_NNS at_IN a_DT density_NN of_IN 0_CD ._. 3_CD ×_NN
          106_CD cells_NNS /_NN 35_CD mm_NN plate_NN ._. Due_JJ to_TO the_DT use_NN of_IN primary_JJ cells_NNS
          rather_RB than_IN cell_NN lines_NNS ,_, there_EX are_VBP variations_NNS in_IN cellular_JJ
          responses_NNS between_IN sets_NNS of_IN cells_NNS ._. Therefore_RB ,_, internal_JJ
          controls_NNS were_VBD always_RB included_VBN and_CC results_NNS from_IN different_JJ
          batches_NNS of_IN cells_NNS were_VBD not_RB averaged_VBN ._. Secondary_JJ cultures_NNS
          were_VBD treated_VBN with_IN 750_CD ng_NN /_NN ml_NN cCAF_NN [_NN 68_CD nM_NN ]_NN or_CC its_PRP$ terminal_NN
          peptides_NNS in_IN 199_CD /_NN tryptose_NN phosphate_NN broth_NN and_CC 2_CD %_NN donor_NN
          calf_NN serum_NN ._. This_DT dose_NN of_IN cCAF_NN was_VBD chosen_VBN because_IN it_PRP was_VBD
          the_DT optimal_NN dose_NN for_IN inducing_VBG differentiation_NN of_IN
          myofibroblasts_NNS ,_, cells_NNS known_VBN to_TO produce_VB large_JJ amounts_NNS of_IN
          ECM_NNP [_NN 4_CD ]_NN ._. Media_NNP was_VBD changed_VBN and_CC new_JJ cCAF_NN or_CC peptides_NNS
          added_VBD every_DT day_NN for_IN 4_CD days_NNS ._.
        
        
          Immunoblotting_NNP
          Proteins_NNPS were_VBD extracted_VBN from_IN the_DT cells_NNS after_IN 4_CD days_NNS of_IN
          treatment_NN ,_, using_VBG 150_CD mM_NN RIPA_NNP buffer_NN containing_VBG protease_NN
          inhibitors_NNS ._. Protein_NNP concentrations_NNS were_VBD determined_VBN using_VBG
          the_DT DC_NNP protein_NN assay_NN kit_NN (_( Bio-_NNP Rad_NNP )_) and_CC samples_NNS were_VBD
          adjusted_VBN to_TO contain_VB equal_JJ amounts_NNS of_IN protein_NN ._. Proteins_NNPS
          were_VBD separated_JJ on_IN 7_CD ._. 5_CD %_NN Doucet_NNP gels_NNS [_NN 48_CD ]_NN and_CC transferred_VBN
          to_TO nitrocellulose_NN was_VBD performed_VBN using_VBG a_DT wet-transfer_JJ
          apparatus_NN (_( Bio-_NNP Rad_NNP )_) at_IN 100_CD V_NNP for_IN 45_CD min_NN ._. The_DT membranes_NNS
          were_VBD blocked_VBN for_IN 1_CD h_NN in_IN 5_CD %_NN milk_NN in_IN TTBS_NNP and_CC then_RB
          incubated_JJ overnight_JJ at_IN 4_CD °_NN C_NNP in_IN primary_JJ antibody_NN (_( 1_CD :_: 50_CD
          anti-_NN Coll_NNP I_PRP ,_, anti-_NN Coll_NNP III_NNP and_CC anti-_NN FN_NNP ,_, 1_CD :_: 100_CD TIMP-_NNP 1_CD ,_,
          1_CD :_: 500_CD anti-_NN MMP-_NNP 1_CD and_CC anti-_NN TIMP-_NNP 2_CD ,_, 1_CD :_: 1000_CD anti-_NN TN_NNP )_) ,_, in_IN 1_CD %_NN
          milk_NN in_IN TTBS_NNP ._. The_DT membranes_NNS were_VBD washed_VBN 3_CD times_NNS for_IN 10_CD
          min_NN each_DT with_IN TTBS_NNP ,_, incubated_JJ in_IN anti-mouse_JJ or_CC
          anti-rabbit_JJ HRP_NNP (_( 1_CD :_: 10_CD ,_, 000_CD )_) in_IN 1_CD %_NN milk_NN for_IN 1_CD hr_NN and_CC washed_VBN
          as_IN above_IN ,_, the_DT bands_NNS visualized_JJ using_VBG the_DT ECL_NNP (_( Amersham_NNP )_) ._.
          Densitometry_NNP was_VBD performed_VBN using_VBG BandScan_NNP software_NN
          (_( Glyko_NNP )_) ._.
        
        
          Immunostaining_NNP
          At_IN the_DT end_NN of_IN treatment_NN ,_, the_DT cells_NNS were_VBD rinsed_JJ with_IN
          PBS_NNP ,_, fixed_VBN and_CC permeabilized_JJ in_IN 4_CD %_NN paraformaldehyde_NN with_IN
          0_CD ._. 15_CD %_NN Triton_NNP X-_NNP 100_CD ._. After_IN fixation_NN ,_, the_DT cells_NNS were_VBD washed_VBN
          and_CC then_RB incubated_JJ with_IN PBS_NNP containing_VBG 0_CD ._. 1_CD M_NNP glycine_NN for_IN
          10_CD min_NN ._. Cells_NNP were_VBD blocked_VBN for_IN 30_CD min_NN with_IN 10_CD %_NN goat_NN serum_NN
          in_IN PBS_NNP ,_, incubated_JJ with_IN primary_JJ antibody_NN (_( 1_CD :_: 100_CD )_) in_IN
          1_CD %_NN BSA_NNP /_NN PBS_NNP for_IN 1_CD hr_NN at_IN room_NN temperature_NN (_( RT_NNP )_) ,_, and_CC washed_VBD
          three_CD times_NNS with_IN 0_CD ._. 1_CD %_NN BSA_NNP /_NN PBS_NNP for_IN 10_CD min_NN each_DT ._. The_DT cells_NNS
          were_VBD then_RB incubated_JJ in_IN secondary_JJ antibody_NN in_IN 1_CD %_NN BSA_NNP /_NN PBS_NNP
          for_IN 1_CD hr_NN at_IN RT_NNP ,_, washed_VBD three_CD times_NNS for_IN 10_CD min_NN with_IN 0_CD ._. 1_CD %_NN
          BSA_NNP in_IN PBS_NNP and_CC mounted_VBD with_IN Vectashield_NNP ._.
        
        
          Zymography_NNP
          Zymography_NNP was_VBD performed_VBN using_VBG denaturing_VBG
          polyacrylamide_NN gels_NNS according_VBG to_TO the_DT protocol_NN of_IN ref_NN ._. [_NN
          49_CD ]_NN ._. Gels_NNP to_TO test_VB for_IN gelatinolytic_JJ activity_NN contained_VBD
          1_CD %_NN gelatin_NN (_( Sigma_NNP )_) and_CC those_DT that_WDT tested_VBD for_IN caseinolytic_JJ
          activity_NN had_VBD 1_CD %_NN casein_NN (_( Sigma_NNP )_) ._. 5_LS μl_NN of_IN 0_CD ._. 25_CD %_NN
          trypsin-_NN EDTA_NNP (_( Gibco-_NNP BRL_NNP )_) was_VBD used_VBN as_IN a_DT positive_JJ control_NN
          for_IN the_DT casein_NN zymogram_NN ._.
        
        
          Plasminogen_NNP activity_NN assay_NN
          A_DT chromogenic_JJ plasminogen_NN activator_NN substrate_NN
          (_( Boc-_NNP Val-_NNP Gly-_NNP Arg-β_NNP NA_NNP ._. AcOH_NNP )_) was_VBD purchased_VBN from_IN Calbiochem_NNP ._.
          50_CD μl_NN of_IN a_DT 10_CD mM_NN stock_NN solution_NN of_IN substrate_NN in_IN water_NN was_VBD
          added_VBN to_TO 200_CD μl_NN 0_CD ._. 1_CD mM_NN HEPES_NNP buffer_NN pH_NN 8_CD ._. 0_CD and_CC heated_VBN to_TO
          25_CD °_NN C_NNP ._. 25_CD μl_NN fibroblast_NN substrate_NN was_VBD added_VBN to_TO the_DT
          substrate_NN and_CC incubated_JJ for_IN 30_CD min_NN ._. Absorbance_NNP was_VBD then_RB
          read_VB at_IN 405_CD nm_NN ._. Positive_JJ control_NN :_: Supernatant_NNP from_IN Rous_NNP
          sarcoma_NN virus-transformed_JJ CEFs_NNP (_( tCEFs_NNS )_) ,_, which_WDT are_VBP known_VBN
          to_TO produce_VB high_JJ levels_NNS of_IN PA_NNP ._.
        
        
          Inhibition_NNP of_IN TN_NNP expression_NN
          For_IN these_DT experiments_NNS we_PRP used_VBD phosphothioated_JJ
          antisense_NN oligodeoxynucleotide_NN (_( ODN_NNP )_) ,_, synthesized_JJ and_CC
          HPLC_NNP purified_JJ by_IN Sigma_NNP Genosys_NNP ,_, to_TO block_VB the_DT TN_NNP
          production_NN ._. The_DT sequences_NNS for_IN the_DT oligonucleotides_NNS were_VBD
          the_DT same_JJ as_IN previously_RB described_VBD [_NN 50_CD ]_NN except_IN that_IN we_PRP
          used_VBD phosphothioated_JJ oligos_NNS rather_RB than_IN morpholino_NN
          oligos_NNS ._. The_DT antisense_NN sequence_NN of_IN the_DT ODN_NNP was_VBD
          5_CD '_POS -_: GGAGTCCCATTGTAGTGCTCAGTTC-_NNP 3_CD '_'' ._. The_DT sense_NN strand_NN of_IN this_DT
          ODN_NNP was_VBD used_VBN as_IN control_NN
          (_( 5_CD '_POS -_: GAACTGAGCACTACAATGGGACTCC-_NNP 3_CD '_POS )_) ._. When_WRB preparing_VBG the_DT
          cell_NN cultures_NNS ,_, 1_CD μM_NN and_CC 2_CD μM_NN of_IN antisense_NN or_CC sense_NN ODN_NNP
          were_VBD added_VBN to_TO the_DT cells_NNS at_IN plating_VBG ._. The_DT cells_NNS where_WRB
          treated_VBN with_IN antisense_NN or_CC sense_NN ODN_NNP and_CC cCAF_NN every_DT 24_CD hrs_NNS
          for_IN 3_CD days_NNS to_TO allow_VB accumulation_NN of_IN the_DT ECM_NNP
          molecules_NNS ._.
        
        
          Northerns_NNP
          Total_NNP RNA_NNP was_VBD extracted_VBN using_VBG TRIzol_NNP reagent_NN from_IN
          untreated_JJ fibroblasts_NNS and_CC fibroblasts_NNS treated_VBN with_IN 750_CD
          ng_NN /_NN ml_NN cCAF_NN for_IN 4_CD -_: 48_CD hrs_NNS ._. Transfer_NN of_IN RNA_NNP to_TO membrane_NN was_VBD
          performed_VBN as_RB previously_RB described_VBD [_NN 51_CD ]_NN ._. RNA_NNP probes_NNS
          were_VBD made_VBN using_VBG the_DT Strip-_NNP EZ_NNP kit_NN from_IN Ambion_NNP (_( Arlington_NNP ,_,
          TX_NNP )_) ._. Membranes_NNP were_VBD prehybridized_JJ for_IN 2_CD hrs_NNS in_IN Ambion_NNP
          Hybridization_NNP buffer_NN at_IN 62_CD °_NN C_NNP ,_, and_CC hybridized_JJ O_NNP /_NN N_NNP at_IN 62_CD °_NN C_NNP ._.
          Membranes_NNP were_VBD washed_VBN with_IN 2_CD ×_NN SSC_NNP /_NN 0_CD ._. 1_LS %_NN SDS_NNP at_IN 62_CD °_NN C_NNP and_CC
          exposed_VBN to_TO film_NN for_IN 6_CD -_: 48_CD hrs_NNS ._.
        
        
          RT-PCR_NNP
          Total_NNP RNA_NNP was_VBD extracted_VBN as_IN above_IN ._. RT-PCR_NNP was_VBD performed_VBN
          using_VBG the_DT Promega_NNP Access_NNP RT-PCR_NNP System_NNP ,_, following_VBG
          Promega_NNP 's_POS instructions_NNS ._. The_DT first_JJ strand_NN was_VBD synthesized_JJ
          at_IN 48_CD °_NN C_NNP and_CC DNA_NNP was_VBD amplified_VBN at_IN 95_CD °_NN C_NNP 45_CD sec_NN ,_, 55_CD °_NN C_NNP 1_CD min_NN ,_,
          68_CD °_NN C_NNP 1_CD ._. 5_CD min_NN for_IN 40_CD cycles_NNS ._. 3_LS μl_NN Quantum_NNP mRNA_NN classic_JJ 18_CD S_NNP
          primers_NNS from_IN Ambion_NNP were_VBD used_VBN to_TO quantify_VB total_JJ RNA_NNP
          levels_NNS ._. Primers_NNP used_VBD for_IN TN_NNP amplification_NN :_: sense_NN
          5_CD '_POS AAATGCATCTGCGAGGGC_NNP ,_, antisense_NN
          5_CD "_'' GGAAGCTTGTTATTGCAGTCCTTCGG_NNP [_NN 41_CD ]_NN ._.
        
        
          Wounding_NNP experiment_NN
          Full-thickness_NNP excision_NN wounds_NNS (_( approximately_RB 0_CD ._. 5_CD ×_NN
          0_CD ._. 5_CD cm_NN )_) were_VBD made_VBN on_IN the_DT underside_NN of_IN the_DT wings_NNS of_IN 2_CD
          week-old_JJ chicks_NNS ,_, using_VBG a_DT scalpel_NN blade_NN ._. The_DT left_VBN wing_NN was_VBD
          treated_VBN with_IN vehicle_NN alone_RB ,_, and_CC the_DT right_JJ wing_NN with_IN 1_CD μg_NN
          cCAF_NN ._. The_DT wounds_NNS were_VBD photographed_VBN immediately_RB after_IN
          wounding_VBG and_CC then_RB covered_VBN with_IN Biocclusive_NNP bandage_NN ._. 50_CD μl_NN
          vehicle_NN or_CC cCAF_NN were_VBD deposited_VBN through_IN the_DT bandage_NN onto_IN
          the_DT wound_NN using_VBG a_DT 30_CD -_: gauge_VB needle_NN ._. This_DT procedure_NN was_VBD
          repeated_VBN the_DT next_JJ day_NN and_CC every_DT other_JJ day_NN thereafter_RB on_IN
          days_NNS 3_CD ,_, 5_CD and_CC 7_CD ._. Samples_NNP were_VBD collected_VBN at_IN days_NNS 3_CD and_CC 7_CD
          post-wounding_JJ for_IN ECM_NNP analysis_NN ._. All_DT experimental_JJ work_NN
          with_IN animals_NNS reported_VBD here_RB was_VBD done_VBN under_IN full_JJ compliance_NN
          with_IN our_PRP$ animal_NN protocol_NN approved_VBN by_IN appropriate_JJ campus_NN
          authorities_NNS ._.
        
        
          Preparation_NNP and_CC staining_VBG of_IN wing_NN sections_NNS
          At_IN the_DT specified_VBN time_NN points_NNS ,_, chickens_NNS were_VBD euthanized_JJ
          with_IN sodium_NN pentobarbitol_NN ._. The_DT wounded_VBN wings_NNS were_VBD
          collected_VBN and_CC fixed_VBN for_IN 18_CD hrs_NNS in_IN 4_CD %_NN paraformaldehyde_NN and_CC
          decalcified_JJ for_IN 3_CD days_NNS in_IN 5_CD %_NN formic_JJ acid_NN ,_, 2_CD ._. 5_CD %_NN
          formaldehyde_NN at_IN 4_CD °_NN C_NNP ._. The_DT tissue_NN was_VBD embedded_VBN in_IN paraffin_NN
          and_CC sectioned_JJ ._. Sections_NNP were_VBD stained_JJ with_IN Masson_NNP
          Trichrome_NNP to_TO visualize_VB interstitial_NN collagen_NN ._. Other_JJ
          sections_NNS were_VBD immunolabeled_JJ for_IN FN_NNP or_CC TN_NNP ._. Sections_NNP were_VBD
          deparaffinized_JJ in_IN 3_CD changes_NNS of_IN Hemo-_NNP De_NNP for_IN 15_CD min_NN each_DT
          and_CC rehydrated_JJ in_IN a_DT descending_VBG ethanol_NN series_NN (_( 5_CD min_NN
          each_DT :_: 100_CD %_NN ,_, 95_CD %_NN ,_, 70_CD %_NN ,_, 50_CD %_NN ,_, 30_CD %_NN ethanol_NN )_) ._. After_IN rinsing_VBG
          with_IN PBS_NNP ,_, sections_NNS were_VBD fixed_VBN in_IN 2_CD %_NN paraformaldehyde_NN for_IN
          1_CD hr_NN ._. Autofluorescence_NNP and_CC non-specific_JJ staining_VBG were_VBD
          blocked_VBN for_IN 30_CD min_NN in_IN 0_CD ._. 1_CD M_NNP glycine_NN in_IN PBS_NNP ,_, followed_VBN by_IN
          30_CD min_NN in_IN 1_CD %_NN Evans_NNP Blue_NNP in_IN PBS_NNP to_TO quench_NN red_JJ blood_NN cell_NN
          autofluorescence_NN ._. Sections_NNP were_VBD incubated_JJ with_IN anti-_NN FN_NNP or_CC
          anti-_NN TN_NNP antibodies_NNS (_( 1_CD :_: 50_CD )_) in_IN 1_CD %_NN BSA_NNP in_IN PBS_NNP for_IN 2_CD hr_NN at_IN
          room_NN temperature_NN ._. After_IN 3_CD ×_NN 10_CD min_NN washes_NNS in_IN 0_CD ._. 1_CD %_NN BSA_NNP in_IN
          PBS_NNP ,_, the_DT sections_NNS were_VBD incubated_JJ for_IN 40_CD min_NN with_IN
          anti-mouse_JJ Alexa_NNP antibody_NN (_( 1_CD :_: 200_CD )_) in_IN 1_CD %_NN BSA_NNP in_IN PBS_NNP ._. They_PRP
          were_VBD then_RB washed_VBN and_CC mounted_VBN with_IN Vectashield_NNP ._.
        
        
          Protein_NNP extracts_NNS of_IN wounds_NNS
          Wound_NNP tissues_NNS were_VBD immediately_RB frozen_VBN on_IN dry_JJ ice_NN and_CC
          stored_VBD at_IN -_: 70_CD °_NN C_NNP ._. To_TO extract_VB protein_NN ,_, the_DT tissue_NN was_VBD
          ground_VBN with_IN glass_NN beads_NNS in_IN a_DT mortar_NN and_CC pestle_NN on_IN dry_JJ
          ice_NN ._. The_DT powdered_JJ tissue_NN was_VBD dissolved_VBN in_IN RIPA_NNP containing_VBG
          300_CD mM_NN salt_NN and_CC a_DT cocktail_NN of_IN protease_NN inhibitors_NNS ,_, and_CC
          vortexed_JJ vigorously_RB ._. After_IN centrifugation_NN ,_, the_DT
          supernatant_NN was_VBD used_VBN in_IN immunoblots_NNS ._.
        
        
          Transwell_NNP assay_NN for_IN migration_NN
          1_LS ×_NN 10_CD 6_CD cells_NNS in_IN 100_CD μl_NN 199_CD medium_NN containing_VBG 2_CD %_NN serum_NN
          were_VBD plated_JJ on_IN the_DT underside_NN of_IN transwell_NN membranes_NNS by_IN
          inverting_VBG the_DT insert_NN ._. They_PRP were_VBD allowed_VBN to_TO adhere_VB for_IN 30_CD
          minutes_NNS ,_, then_RB the_DT well_NN was_VBD turned_VBN right_JJ side_NN up_RB and_CC both_DT
          sides_NNS of_IN the_DT well_NN were_VBD filled_VBN with_IN serum-containing_JJ
          medium_NN ._. The_DT cells_NNS were_VBD allowed_VBN to_TO recover_VB for_IN 24_CD hrs_NNS ,_, and_CC
          express_VB the_DT cCAF_NN receptors_NNS ._. Then_RB the_DT medium_NN in_IN the_DT top_NN
          well_RB was_VBD changed_VBN to_TO serum-free_JJ medium_NN containing_VBG 50_CD -_: 1000_CD
          ng_NN /_NN ml_NN cCAF_NN or_CC 2_CD %_NN serum_NN (_( positive_JJ control_NN )_) ;_: serum_NN free_JJ
          medium_NN alone_RB was_VBD placed_VBN in_IN the_DT bottom_NN well_RB ._. The_DT cells_NNS
          were_VBD allowed_VBN to_TO migrate_VB towards_IN the_DT chemoattractant_NN for_IN
          24_CD hrs_NNS ._. The_DT cells_NNS on_IN the_DT underside_NN of_IN the_DT membrane_NN were_VBD
          removed_VBN with_IN a_DT cotton_NN swab_NN ._. The_DT membranes_NNS were_VBD then_RB fixed_VBN
          and_CC stained_JJ with_IN 2_CD %_NN toludine_NN blue_JJ in_IN formaldehyde_NN ._. To_TO
          determine_VB the_DT number_NN of_IN migrated_JJ cells_NNS ,_, all_DT cells_NNS on_IN the_DT
          upper_JJ side_NN of_IN the_DT membrane_NN were_VBD counted_VBN ._. Control_NNP for_IN
          chemotaxis_NNS was_VBD performed_VBN by_IN adding_VBG 1000_CD ng_NN /_NN ml_NN cCAF_NN to_TO
          both_DT wells_NNS of_IN the_DT Transwell_NNP unit_NN ._.
        
        
          Cloning_NNP ring_NN assay_NN for_IN migration_NN
          1_LS ×_NN 10_CD 6_CD cells_NNS in_IN 100_CD μl_NN 199_CD medium_NN containing_VBG 2_CD %_NN serum_NN
          were_VBD plated_JJ in_IN a_DT cloning_VBG ring_NN in_IN a_DT 35_CD mm_NN plate_NN ._. They_PRP were_VBD
          allowed_VBN to_TO adhere_VB for_IN 1_CD hour_NN ,_, then_RB the_DT ring_NN was_VBD removed_VBN ,_,
          the_DT culture_NN medium_NN added_VBD to_TO the_DT plate_NN and_CC the_DT cells_NNS
          photographed_VBN on_IN a_DT phase-contrast_JJ microscope_NN to_TO record_VB the_DT
          area_NN of_IN the_DT cells_NNS and_CC the_DT edge_NN of_IN the_DT ring_NN ._. cCAF_NN was_VBD then_RB
          added_VBN at_IN various_JJ doses_NNS (_( 0_CD -_: 1000_CD ng_NN /_NN ml_NN )_) ._. The_DT following_VBG day_NN
          the_DT medium_NN was_VBD changed_VBN and_CC the_DT cells_NNS were_VBD treated_VBN again_RB ._.
          On_IN the_DT third_JJ day_NN after_IN plating_VBG ,_, the_DT cells_NNS were_VBD
          photographed_VBN once_RB more_JJR before_IN the_DT experiment_NN was_VBD
          terminated_VBN ._. To_TO determine_VB the_DT extent_NN of_IN cell_NN migration_NN ,_, we_PRP
          measured_VBD the_DT distance_NN between_IN the_DT edge_NN where_WRB the_DT cloning_VBG
          ring_NN was_VBD at_IN day_NN zero_CD and_CC the_DT edge_NN of_IN the_DT culture_NN
          delineated_JJ by_IN the_DT migrating_VBG front_NN of_IN the_DT cells_NNS on_IN the_DT 3_CD
          rdday_NN ._.
        
        
          In_IN situhybridization_NN
          Fibroblast_NNP cultures_NNS and_CC probes_NNS were_VBD prepared_VBN as_IN
          described_VBN previously_RB (_( Martins-_NNP Green_NNP and_CC Bissell_NNP ,_, 1990_CD )_) ._.
          Briefly_NNP ,_, probes_NNS were_VBD prepared_VBN as_IN follows_VBZ :_: 1_CD μg_NN of_IN
          pGEM_NN 1_CD /_NN cCAF_NN cDNA_NN was_VBD transcribed_JJ for_IN 1_CD 1_CD /_NN 2_CD h_NN at_IN 37_CD °_NN C_NNP in_IN a_DT
          cocktail_NN containing_VBG 100_CD μM_NN each_DT of_IN 3_CD H-ATP_NNP and_CC 3_CD H-UTP_NNP
          (_( Amersham_NNP Corp_NNP ._. )_) ,_, 1_CD mM_NN each_DT GTP_NNP and_CC CTP_NNP ,_, 120_CD mM_NN
          dithiothreitol_NN ,_, and_CC 100_CD U_NNP of_IN T_NN 7_CD polymerase_NN (_( Amersham_NNP
          Corop_NNP ._. )_) ._. The_DT probe_NN was_VBD separated_JJ from_IN the_DT free_JJ
          nucleotides_NNS in_IN a_DT Sephadex_NNP G-_NNP 50_CD column_NN equilibrated_JJ with_IN
          50_CD mM_NN tris_NNS (_( hydroxymethyl_NN )_) aminomethane_NN pH_NN 8_CD ._. 0_CD ,_, 15_CD mM_NN
          NaCl_NNP ,_, and_CC 1_CD mM_NN EDTA_NNP ._. For_IN 
          in_IN situ_NN hybridization_NN ,_, cells_NNS were_VBD
          fixed_VBN in_IN 4_CD %_NN paraformaldehyde_NN containing_VBG 5_CD mM_NN MgCl_NNP 
          2_CD ,_, incubated_JJ in_IN 0_CD ._. 1_CD M_NNP glycine_NN for_IN 10_CD
          min_NN ,_, dehydrated_JJ 3_CD min_NN each_DT in_IN 30_CD ,_, 70_CD ,_, and_CC 100_CD %_NN ethanol_NN ,_,
          and_CC allowed_VBD to_TO dry_VB ._. Prehybridization_NNP was_VBD performed_VBN in_IN a_DT
          solution_NN containing_VBG 60_CD %_NN formamide_NN ,_, 0_CD ._. 1_CD M_NNP piperazine-_NN 
          N_NNP ,_, N_NNP '_POS -_: bis_NNS (_( 2_CD -_: ethanesulfonic_JJ acid_NN )_) pH_NN
          6_CD ._. 4_CD ,_, 0_CD ._. 4_CD M_NNP NaCl_NNP ,_, and_CC 0_CD ._. 2_CD mg_NN /_NN ml_NN of_IN 
          E_NNP ._. coli_NNS tRNA_NN (_( Sigma_NNP ,_, St_NNP ._. Louis_NNP ,_, MO_NNP )_)
          for_IN 2_CD h_NN at_IN 55_CD °_NN C_NNP with_IN gentle_JJ shaking_VBG ._. The_DT hybridization_NN
          solution_NN was_VBD the_DT same_JJ as_IN the_DT prehybridization_NN solution_NN
          but_CC contained_VBD 10_CD 6_CD cpm_NN /_NN ml_NN of_IN the_DT cCAF_NN probe_NN or_CC with_IN the_DT
          same_JJ number_NN of_IN counts_NNS of_IN the_DT vector_NN probe_NN and_CC incubated_JJ
          at_IN 55_CD °_NN C_NNP for_IN 48_CD h_NN with_IN gentle_JJ shaking_VBG ._. At_IN the_DT end_NN of_IN this_DT
          period_NN ,_, the_DT cultures_NNS were_VBD washed_VBN twice_RB with_IN 2_CD ×_NN SSC_NNP +_NN 0_CD ._. 1_CD %_NN
          Triton-_NNP X_NNP 100_CD for_IN 1_CD h_NN followed_VBN by_IN two_CD more_JJR washes_NNS with_IN
          0_CD ._. 1_CD ×_NN SSC_NNP +_NN 0_CD ._. 1_CD %_NN Triton-_NNP X_NNP 100_CD ,_, all_DT at_IN 55_CD °_NN C_NNP in_IN the_DT shaker_NN ._.
          The_DT cultures_NNS were_VBD allowed_VBN to_TO dry_VB ,_, then_RB covered_VBN with_IN
          emulsion_NN and_CC processed_VBN as_IN described_VBN previously_RB [_NN 6_CD ]_NN
          ._.
        
      
      
        Author_NN 's_POS contributions_NNS
        JEF_NNP carried_VBD out_RP all_DT studies_NNS except_IN for_IN the_DT TN_NNP antisense_NN
        inhibition_NN experiment_NN ._. LW_NNP and_CC QJL_NNP initials_NNS carried_VBD out_RP the_DT
        TN_NNP antisense_NN studies_NNS ._. MMG_NNP initials_NNS conceived_VBD and_CC designed_VBN ,_,
        with_IN JEF_NNP ,_, the_DT studies_NNS ,_, and_CC contributed_VBD to_TO manuscript_NN
        preparation_NN and_CC submission_NN ._.
        All_DT authors_NNS read_VBP and_CC approved_VBD the_DT final_JJ manuscript_NN ._.
      
      
        List_NN of_IN abbreviations_NNS used_VBN
        cCAF_NN chicken_NN Chemotactic_NNP and_CC Angiogenic_NNP Factor_NN
        CEFs_NNP chicken_NN embryo_NN fibroblasts_NNS
        Coll_NNP collagen_NN
        ECM_NNP extracellular_NN matrix_NN
        FN_NNP fibronectin_NN
        IL-_NNP 8_CD interleukin-_NN 8_CD
        MCP-_NNP 1_CD monocyte_NN chemotactic_JJ protein-_NN 1_CD
        MGSA_NNP melanoma_NN growth_NN stimulatory_NN activity_NN
        MMP_NNP matrix_NN metalloprotease_NN
        PA_NNP plasminogen_NN activator_NN
        TGFβ_NNP 1_CD transforming_VBG growth_NN factor_NN β_NN 1_CD
        TIMP_NNP tissue_NN inhibitor_NN of_IN metalloprotease_NN
        TN_NNP tenascin_NN
      
    
  
